Abeona Therapeutics(us:ABEO)

    5.64

    -1.05%

    Updated on 2024-12-23

    Open:5.68
    Close:5.64
    High:5.72
    Low:5.58
    Pre Close:5.70
    Volume:137190.00
    Amount:773744.38
    Turnover:0.32%
    Shares:43.47M
    MarketCap:245.18M
    Total 1 records
    codechangetotalincreasedecreaserps5rps10rps15rps20

    Biote...

    BK2069

    +0.60%67230535331142442

    About

    Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.
    Address:6555 Carnegie Avenue,4th floor

    Market Movers